Steris (STE) Tops Q1 EPS by 25c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
STERIS (STE) PT Raised to $254 at Needham & Company
August 10, 2021 12:05 PM EDTNeedham & Company analyst Mike Matson raised the price target on STERIS (NYSE: STE) to $254.00 (from $233.00) while maintaining a Buy rating.
The analyst commented, "STE's F1Q22 revenue and EPS beat consensus. Organic revenue growth improved significantly from the prior quarter as STE lapped the... More
